reference/29698698

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29698698

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1748
issn	1533-4406 0028-4793
issueIdentifier	18
pageRange	1738-1748
publicationName	The New England journal of medicine
startingPage	1738
bibliographicCitation	Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. N Engl J Med. 2016 Nov 03;375(18):1738–48. doi: 10.1056/nejmoa1609709. PMID: 27717303.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cfda21287ef40d98c15b2a9db59a0dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_372843775117894ede80c51478fa44bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0406ba536c4a8be372b1bbc6ee7b78b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39ad20595fb0366ea6f4aafe5b5f1474 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4545e1c9ff00235d75b83c4d55965739 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_943353ddbc48f5586b7cdc4301a5aa8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cfaa95e9ffcbfeffcf05eb78795227e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c988e7ce2edccf019a170273057e7201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fd35067fdaa4dff8890e42f4cf32420 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8c32e3b9a4381fe7f77afc7262f7342 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d67c0ce3c08398c539fb3be1ce115a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1c82148040d368a755c75dad259a5fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab1d2a67aa32695d687eb5d0fbacd664 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e074738595b793d02b7efcb16ceb8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cad821a349cdaa783efe0f6ecacf6002 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0347-5066 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1774a80c47c4f6471756c460fa2275d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4cc44a2a678068a27d04be1dfb3e23c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0dfbda93c2ba171d088a824ec52497a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc08a0771987495e904062ca6deb4614 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_339ddb03ef12af911a45cc91e8e26b99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44dcd642a699473ed13db6ac8f72d24d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42b9ab9f77f0b571bfd3cfbcd1a8ccca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beb2de6b3bf42c53b5c3def48b8aca16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ff039fc0c09f0cbadfbcaf6ad499d2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a6ef8ae11aa90b1e2a9fa31701bd496 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b5c74624aa4826ad499c0497c2f9537 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dbd6c442b3c8a586c50ef038c848d30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b136b7478bf336814ead08a146c43731 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86c24b482f90fed459ab4554d589186e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7319823863a3b78f42b048985f1a0d5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaaa8f36fed87a2516a2a06a77990556 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3ec5af250137aefb0cddd0a44a29c56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_005df212181f934e0a6ba6fbcd5dc3da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5700626320db9c363a36ae114b6a2f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_436ce5b4c7f0cdaf80619bbaedca824c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b24fa2dd319213564605f6cd1974e84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a258b4c0f450cf0f3cbc2e3b9d2e586
date	2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27717303 https://doi.org/10.1056/nejmoa1609709
isPartOf	https://portal.issn.org/resource/ISSN/1533-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985 https://portal.issn.org/resource/ISSN/0028-4793
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M000640349 http://id.nlm.nih.gov/mesh/M0495206 http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0000964 http://id.nlm.nih.gov/mesh/M000595784 http://id.nlm.nih.gov/mesh/M0018169 http://id.nlm.nih.gov/mesh/M0018613
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014230Q000008 http://id.nlm.nih.gov/mesh/D009570Q000008 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D011687Q000008 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D000631Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D018719 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011960 http://id.nlm.nih.gov/mesh/D011980 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000077289
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44631912 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178103955

Total number of triples: 99.